COVID-19
Researchers at the University Hospital Basel in Basel, Switzerland, have evaluated the diagnostic performance of a combined rapid antigen test for detecting SARS-CoV-2, influenza virus, and respiratory syncytial virus in symptomatic patients in tertiary care. The study found that the test is effective for detecting these pathogens in samples with
COVID-19
The New Jersey Department of Health has emphasized the importance of staying up to date on routine and annual immunizations, particularly for the upcoming school year and flu season. As National Immunization Awareness Month, the department highlights the role vaccines play in preventing serious illness and disability. Vaccines protect against
COVID-19
Low influenza vaccine coverage among reproductive-aged women in China has raised concerns about the effectiveness of pandemic mitigation strategies. Research published in the journal Vaccines has highlighted the alarming rate of vaccine hesitancy among this demographic, underscoring the need for targeted interventions and policies. A cross-sectional survey conducted in China
AstraZeneca PLC
A recent study published in Vaccine: X has evaluated the comparative effectiveness of live attenuated influenza vaccine (LAIV) and inactivated influenza vaccine (IIV) in children across 13 European countries and the US during the 2019-2023 influenza seasons. The research, conducted by AstraZeneca, aimed to assess the vaccine effectiveness (VE) of
Influenza
Researchers from the Icahn School of Medicine at Mount Sinai have made significant progress in the development of mucosal influenza vaccines, which protect the site of viral entry. By analyzing the immunogenicity and protective efficacy of a mucosal recombinant neuraminidase-based influenza virus vaccine, the team demonstrated the potential of bacterial
COVID-19
Kieran Shingler's life was turned upside down when he began experiencing flu-like symptoms, which were initially dismissed as seasonal flu or Covid-19. However, as the weeks passed, his condition worsened, and he was eventually diagnosed with a grade three astrocytoma, an aggressive cancerous growth in his brain. Despite
COVID-19
Kieran Shingler, a 26-year-old HGV driver, thought he had contracted COVID-19 in 2022, but his symptoms persisted, and he was eventually diagnosed with a grade three astrocytoma, a fast-growing cancerous tumor on his brain. Despite undergoing radiotherapy and chemotherapy, the tumor began to grow again, and Kieran's health
COVID-19
A recent study has found that respiratory viruses, including the flu and COVID-19, may be able to "wake up" dormant cancer cells in patients who have a history of cancer. Researchers tested this hypothesis in mice that contained disseminated cancer cells, which are cells that have broken away
COVID-19
With students returning to classrooms in both public and private schools in the state of Parana, Brazil, the State Government is reiterating the importance of school vaccinations to protect against various diseases. The joint task force between the Departments of Education (Seed) and Health (Sesa) aims to update students'
COVID-19
The Australian Health Protection Committee (AHPC) has acknowledged the current increase in respiratory disease activity across Australia, with reported influenza activity rising since early May 2025. This increase is consistent with expected seasonal patterns, although a higher proportion of influenza B infections is being seen, particularly in school-aged children. Hospitalisations
COVID-19
Researchers at the Schulich School of Medicine and Dentistry have made significant discoveries regarding the potential use of a synthetic host defense peptide, D-3006, in treating SARS-CoV-2 and other respiratory viral infections. According to a study published in Antimicrobial Agents and Chemotherapy, D-3006 demonstrated broad-spectrum antiviral activity, effectively inhibiting SARS-CoV-2
COVID-19
Researchers have published new findings in the journal Vaccine indicating that prior COVID-19 infection may not significantly impact the response to influenza A components in the 2020-2021 Fluzone vaccine. However, older age consistently correlated with reduced antibody responses across multiple readouts, suggesting a need for targeted approaches to improve influenza
